Although these chemotherapy agents provide convenience and ease, they are subject to hepatic first-pass metabolism and enzymatic drug-drug interactions.
Amelia L. Persico MBA, PharmD
Advertisement
Articles by Amelia L. Persico MBA, PharmD
Advertisement
Latest Updated Articles
Be Mindful of DDIs Between Analgesics and Oral Cancer DrugsApril 26th 2019
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
2
Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL
3
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
4
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
5